SCHEMBL17846151

SCHEMBL17846151

CCn1ncc2cc(Cl)nc(CC(O)COC[C@@H](N)c3ccccc3)c21

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 12/20 0.41
TACR1 P25103 3/20 0.35
SCN4A P35499 3/20 0.34
BCDIN3D Q7Z5W3 1/20 0.34
HASPIN Q8TF76 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20204244 1.00 MAPK1 (0.41) MAPK1TACR1SCN4ABCDIN3DHASPIN
SCHEMBL19348964 0.86 MAPK1 (0.41) MAPK1
SCHEMBL20204242 0.86 MAPK1 (0.44) MAPK1
SCHEMBL17846021 0.86 MAPK1 (0.44) MAPK1
SCHEMBL20204246 0.85 MAPK1 (0.45) MAPK1
SCHEMBL17846153 0.85 MAPK1 (0.45) MAPK1
SCHEMBL17846128 0.85 HTR2A (0.36) MAPK1
SCHEMBL17846047 0.85 HTR2A (0.36) MAPK1
SCHEMBL17846016 0.83 MAPK1 (0.39) MAPK1TACR1SCN4ABCDIN3DHASPIN
SCHEMBL20204247 0.80 MAPK1 (0.43) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233859-B1 BRIDGED PYRAZOLOPYRIDINE DERIVATIVES AS ERK INHIBITORS USEFUL FOR THE TREATEMENT OF CANCER MERCK SHARP & DOHME (US) 2019-08-07 EP disclosed
US-9988397-B2 ERK inhibitors MERCK SHARP & DOHME CORP. (US) 2018-06-05 US disclosed
EP-3233859-A1 ERK INHIBITORS Merck Sharp & Dohme Corp. (US) 2017-10-25 EP disclosed
WO-2016100051-A1 ERK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-06-23 WO disclosed